Log In
Print
BCIQ
Print
Print this Print this
 

Combivent Respimat, ipratropium bromide/albuterol

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionIpratropium bromide and albuterol propellant-free inhaler
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationChronic obstructive pulmonary disease (COPD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today